Behavioral Health Equity Webinar

Date: September 15, 2022

The Centers for Medicare & Medicaid Services Office of Minority Health (CMS OMH) would like to share this announcement on behalf of the Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Behavioral Health Equity (OBHE).

On Thursday, September 22, 2022, from 1:30 – 3:00 PM ET, SAMHSA OBHE will host a webinar to discuss the need for behavioral health equity to ensure individuals living in underserved communities have access to recovery, treatment, and support.

During the webinar, Dr. Victoria Cargill will discuss:

  • The impact of discrimination, racism, and racial trauma on marginalized individuals living with substance use disorders;
  • Intersecting effects of the social determinants of health;
  • Effective and successful interventions that support substance use disorder treatment for underserved populations;
  • Barriers to equitable treatment, recovery, and support services; and
  • How we move forward together as a nation.

To join the webinar

  • Webinar ID: 161 401 7737
  • Passcode: 393593

About the Presenter:

Victoria Cargill, MD, MSCE IAS-USE

Assistant Commissioner, Baltimore City Health Department

Dr. Victoria Cargill is a Boston and Harvard University trained board-certified internal medicine and HIV physician, and former Assistant Commissioner of Health at the Baltimore City Health Department, overseeing the Ryan White program and Community Risk Reduction/Syringe Support Services. Prior to becoming an Assistant Commissioner, she served as a senior policy analyst and program director for 20 years at the National Institutes of Health (NIH) in both the Office of AIDS Research (OAR) and the Office of Research on Women’s Health (ORWH). At OAR, she was the Director of Minority Research and Clinical Studies, and Acting Director of HIV Therapeutics Research. At ORWH, she served as the Associate Director for Interdisciplinary Research, and grew the U3 program focused on stimulating research on understudied, underreported, and underrepresented women to over $3 million dollars. She has also served as the acting chair of the FDA Antiviral Advisory Committee, including chairing the hearings of the first two U.S.-approved HCV antivirals.

A former co-investigator at the Case Western AIDS Clinical Trials Unit and the creator of an AIDS education and prevention adolescent-focused program that reached over 100,000 teens in five Ohio cities, she has extensive public health and HIV prevention research experience. Currently the principal investigator of a HRSA-funded Ending the HIV Epidemic grant, and the author of over 150 scientific articles, research presentations, book chapters and popular press educational materials, she has been nationally recognized as one of America’s Top Doctors. Dr. Cargill continues to consider patients and communities as her best teachers.